Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity

AIDS

Volumn 16, Issue 17, 2002, Pages 2253-2261

  Campbell, Shahan M ^a   Crowe, Suzanne M ^a,b,c   Mak, Johnson ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Envelope proteins; Lipid; Molecular biology; Retrovirus; Viral infections; Virus proteins

Indexed keywords

CHOLEST 4 EN 3 ONE; CHOLESTEROL DERIVATIVE; METHYL BETA CYCLODEXTRIN; SPHINGOMYELIN;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS ENVELOPE; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION;

BETA-CYCLODEXTRINS; CELL LINE; CHOLESTENONES; CHOLESTEROL; CYCLODEXTRINS; HIV-1; HUMANS; SPHINGOMYELINS; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS REPLICATION;

EID: 0037159920     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200211220-00004     Document Type: Article

References (50)

1. Gelderblom HR. Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS 1991, 5:617-637.
2. Gelderblom HR, Bauer PG, Ozel M, Hoglund P, Niedrig M, Renz H et al. Morphogenesis and morphology of human immunodeficiency virus. In: Membrane Interactions of HIV. Edited by Aloia RC, Curtain CC. New York: Wiley-Liss; 1992: 33-54
3. Aloia RC, Jensen FC, Curtain CC, Mobley PW, Gordon LM. Lipid composition and fluidity of the human immunodeficiency virus. Proc Natl Acad Sci USA 1988, 85:900-904.
4. Gabelman N, Waxman S, Smith W, Douglas SD. Appearance of C-type virus-like particles after co-cultivation of a human tumorcell line with rat (XC) cells. Int J Cancer 1975, 16:355-369.
5. Richardson CD, Vance DE. Biochemical evidence that Semliki Forest virus obtains its envelope from the plasma membrane of the host cell. J Biol Chem 1976, 251:5544-5550.
6. Luan P, Yang L, Glaser M. Formation of membrane domains created during the budding of vesicular stomatitis virus. A model for selective lipid and protein sorting in biological membranes. Biochemistry 1995, 34:9874-9883.
7. Phalen T, Kielian M. Cholesterol is required for infection by Semliki Forest virus. J Cell Biol 1991, 112:615-623.
8. Kielian MC, Helenius A. Role of cholesterol in fusion of Semliki Forest virus with membranes. J Virol 1984, 52:281-283.
9. Scheiffele P, Rietveld A, Wilk T, Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 1999, 274:2038-2044.
10. Lu YE, Cassese T, Kielian M. The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol 1999, 73:4272-4278.
11. Manie SN, Debreyne S, Vincent S, Gerlier D. Measles virus structural components are enriched into lipid raft microdomains: A potential cellular location for virus assembly. J Virol 2000, 74:305-311.
12. Vincent S, Gerlier D, Manie SN. Measles virus assembly within membrane rafts. J Virol 2000, 74:9911-9915.
13. Ali A, Nayak DP. Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 2000, 276: 289-303.
14. Keller P, Simons K. Cholesterol is required for surface transport of influenza virus hemagglutinin. J Cell Biol 1998, 140:1357-1367.
15. Rosenberger CM, Brumell JH, Finlay BB. Microbial pathogenesis: Lipid rafts as pathogen portals. Curr Biol 2000, 10:R823-R825.
16. van der Goot FG, Harder T. Raft membrane domains: From a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 2001, 13:89-97.
17. Quigley JP, Rifkin DB, Reich E. Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology 1971, 46:106-116.
18. Aguilar J.J, Anel A, Tortes JM, Semmel M, Uriel J. Changes in lipid composition of human peripheral blood lymphocytes infected by HIV. AIDS Res Hum Retroviruses 1991, 7:761-765.
19. Aloia RC, Tian H, Jensen FC. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc Natl Acad Sci USA 1993, 90:5181-5185.
20. Campbell SM, Crowe SM, Mak J. Lipid rafts and HIV-1:From viral entry to assembly of progeny virions. J Clin Virol 2001, 22:217-227.
21. Manes S, Mira E, Gomez-Mouton C, Lacalle RA, Keller P, Labrador JP, Martinez AC. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J 1999, 18:6211-6220.
22. Xavier R, Brennan T, Li Q, McCormack C, Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity 1998, 8:723-732.
23. Nieto M, Frade JM, Sancho D, Mellado M, Martinez AC, Sanchez-Madrid F. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J Exp Med 1997, 186:153-158.
24. Vicente-Manzanares M, Montoya MC, Mellado M, Frade JM, del Pozo MA, Nieto M, et al. The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes. Eur J Immunol 1998, 28:2197-2207.
25. Manes S, del Real G, Lacalle RA, Lucas P, Gomez-Mouton C, Sanchez-Palomino S, et al. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 2000, 1:190-196.
26. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE. Lipid rafts and HIV pathogenesis:Host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 2001, 17:1009-1019.
27. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH et al. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991, 253:320-323.
28. Hammache D, Yahi N, Maresca M, Pieroni G, Fantini J. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: Evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J Virol 1999, 73:5244-5248.
29. Harder T, Scheiffele P, Verkade P, Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 1998, 141:929-942.
30. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000, 74:3264-3272.
31. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci USA 2001, 98:13925-13930.
32. Lindwasser OW, Resh MD. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol 2001, 75: 7913-7924.
33. Rousso I, Mixon MB, Chen BK, Kim PS. Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc Natl Acad Sci USA 2000, 97:13523-13525.
34. Richieri SP, Bartholomew R, Aloia RC, Savary J, Gore R, Holt J, et al. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine 1998, 16:119-129.
35. Shehu-Xhilaga M, Crowe SM, Mak J. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J Virol 2001, 75:1834-1841.
36. Terwilliger EF, Cohen EA, Lu YC, Sodroski JG, Haseltine WA. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci USA 1989, 86:5163-5167.
37. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206:935-944.
38. Dettenhofer M, Yu XF. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J Virol 1999, 73:1460-1467.
39. Abacioglu YH, Fouts TR, Laman JD, Claassen E, Pincus SH, Moore JP, et al. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses 1994, 10:371-381.
40. Chesebro B, Wehrly K. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988, 62:3779-3788.
41. Pincus SH, Wehrly K, Chesebro B. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates. J Immunol 1989, 142:3070-3075.
42. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
43. Ostermeyer AG, Beckrich BT, Ivarson KA, Grove KE, Brown DA. Glycosphingolipids are not essential for formation of detergent-resistant membrane rafts in melanoma cells, methyl-beta-cyclodextrin does not affect cell surface transport of a GPI-anchored protein. J Biol Chem 1999, 274:34459-34466.
44. Rietveld A, Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim Biophys Acta 1998, 1376:467-479.
45. Sankaram MB, Thompson TE. Interaction of cholesterol with various glycerophospholiplds and sphingomyelin. Biochemistry 1990, 29:10670-10675.
46. Bittman R, Kasireddy CR, Mattjus P, Slotte JP. Interaction of cholesterol with sphingomyelin in monolayers and vesicles. Biochemistry 1994, 33:11776-11781.
47. Huang J, Feigenson GW. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys J 1999, 76:2142-2157.
48. Xu X, London E. The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 2000, 39:843-849.
49. Brown DA. Interactions between GPI-anchored proteins and membrane lipids. Trends Cell Biol 1992, 2:338-343.
50. Jan JT, Chatterjee S, Griffin DE. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol 2000, 74:6425-6432.